A $90 million fraud case can sound distant until the mechanics come into view: thousands of claims, medical equipment that patients did not need, and public money moving through a system built to pay for care. Federal prosecutors said a former Bay Area resident, 38-year-old Azerbaijani national Anar Rustamov, was charged with aiding and abetting health care fraud and money laundering in a scheme tied to false billing through the Medicare Advantage program. According to the indictment described by prosecutors, claims were submitted over about nine months through an organization called Dublin Helping Hand for blood glucose monitors, orthotic braces, and other equipment that was allegedly not provided, not medically necessary, and not authorized by a clinician. Authorities also said the patients named in the claims were unaware their information had been used, and Rustamov remained at large.
The broader significance is not confined to one defendant or one region. Health care fraud reaches beyond bookkeeping losses because it causes tens of billions of dollars in losses each year, according to the FBI, and the agency says the fallout can include higher premiums, higher taxes, and exposure to unnecessary care. In durable medical equipment cases, the pattern is often deceptively simple: a supplier or shell operation obtains patient identifiers, submits claims for products never delivered or never justified, and seeks reimbursement before a patient realizes anything has been billed in their name. The administrative trail can be enormous, since each billed item may count separately under federal fraud rules, and the financial damage compounds quickly when claims are repeated at scale.
That is one reason equipment-related schemes continue to draw scrutiny from investigators, especially when the alleged activity involves large batches of claims rather than isolated billing disputes. The case also reflects how fraud can ride on trust in familiar-seeming products such as braces, monitors, and other routine devices that do not immediately raise alarm.
Federal agencies have been building a more data-driven response. In the Justice Department’s 2025 national health care fraud takedown, prosecutors announced charges against 324 defendants tied to more than $14.6 billion in intended loss. Officials said CMS also prevented over $4 billion from being paid on false and fraudulent claims, underscoring a shift toward stopping questionable billing before funds leave the system.
The legal framework behind such cases is expansive. The Department of Health and Human Services explains that submitting false claims to Medicare or Medicaid is illegal, and civil penalties can multiply claim by claim. Separate anti-kickback, self-referral, exclusion, and civil monetary penalty rules broaden the government’s reach when billing conduct intersects with referrals, ownership interests, or providers who should not be participating in federal programs at all.
In the Bay Area case, the most striking feature is not only the dollar amount but the ordinariness of the items at the center of it. Equipment claims can blend into the daily churn of health care paperwork, which helps explain why investigators increasingly rely on advanced data analytics to detect unusual billing patterns before they become larger drains on public programs.That makes fraud enforcement less about dramatic raids than about protecting the quiet infrastructure behind routine care, where every false claim competes with legitimate ones for attention, money, and trust.
